BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15972135)

  • 1. [Expansion of erythroid progenitors and CD34+ cells by umbilical cord blood mononuclear cells].
    Zhang JX; Mao P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):429-33. PubMed ID: 15972135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand.
    Ohmizono Y; Sakabe H; Kimura T; Tanimukai S; Matsumura T; Miyazaki H; Lyman SD; Sonoda Y
    Leukemia; 1997 Apr; 11(4):524-30. PubMed ID: 9096693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
    Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haematopoietic action of flt3 ligand on cord blood-derived CD34-positive cells expressing different levels of flt3 or c-kit tyrosine kinase receptor: comparison with stem cell factor.
    Sakabe H; Kimura T; Zeng Z; Minamiguchi H; Tsuda S; Yokota S; Hodohara K; Abe T; Lyman SD; Sonoda Y
    Eur J Haematol; 1998 May; 60(5):297-306. PubMed ID: 9654159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
    Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
    Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophilic cell production by combination of stem cell factor and thrombopoietin from CD34(+) cord blood cells in long-term serum-deprived liquid culture.
    Sawai N; Koike K; Ito S; Mwamtemi HH; Kurokawa Y; Kinoshita T; Sakashita K; Higuchi T; Takeuchi K; Shiohara M; Miyazaki H; Kato T; Komiyama A
    Blood; 1999 Jan; 93(2):509-18. PubMed ID: 9885212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human FLT3 ligand acts on myeloid as well as multipotential progenitors derived from purified CD34+ blood progenitors expressing different levels of c-kit protein.
    Sonoda Y; Kimura T; Sakabe H; Tanimukai S; Ohmizono Y; Nakagawa S; Yokota S; Lyman SD; Abe T
    Eur J Haematol; 1997 Apr; 58(4):257-64. PubMed ID: 9186537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved serum free system for cloning human "pure" erythroid colonies. The role of different growth factors and cytokines on BFU-E formation by the bone marrow and cord blood CD34+ cells.
    Ratajczak J; Marlicz W; MachaliƄski B; Pertusini E; Czajka R; Ratajczak MZ
    Folia Histochem Cytobiol; 1998; 36(2):55-60. PubMed ID: 9606618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a cytokine combination including thrombopoietin for improved transduction of a retroviral gene into G-CSF-mobilized CD34+ human blood cells.
    Kim HJ; Okamoto Y; Ito M; Takaue Y; Kawano Y; Watanabe T; Yamaue T; Tohda Y; Ogose T; Shimada T; Shimosaka A; Kuroda Y
    Stem Cells; 1997; 15(5):347-52. PubMed ID: 9323796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin.
    Hagiwara T; Kodama I; Horie K; Kato T; Miyazaki H
    Exp Hematol; 1998 Mar; 26(3):228-35. PubMed ID: 9502619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of FLT3 ligand in progenitor and primitive hematopoietic cell expansion.
    Poloni A; Douay L; Giarratana MC; Kobari L; Gorin NC; Olivieri A; Leoni P
    Boll Soc Ital Biol Sper; 1997; 73(3-4):55-62. PubMed ID: 9540233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells.
    Traycoff CM; Abboud MR; Laver J; Brandt JE; Hoffman R; Law P; Ishizawa L; Srour EF
    Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro.
    Rusten LS; Lyman SD; Veiby OP; Jacobsen SE
    Blood; 1996 Feb; 87(4):1317-25. PubMed ID: 8608220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flt 3 ligand, MGDF, Epo and G-CSF enhance ex vivo expansion of hematopoietic cell compartments in the presence of SCF, IL-3 and IL-6.
    Kobari L; Giarratana MC; Poloni A; Firat H; Labopin M; Gorin NC; Douay L
    Bone Marrow Transplant; 1998 Apr; 21(8):759-67. PubMed ID: 9603398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro expansion of CD34+/CD41+ cells from human peripheral blood CD34+/CD41- cells: role of cytokines for in vitro proliferation and differentiation of megakaryocytic progenitors.
    Koizumi K; Sawada K; Yamaguchi M; Notoya A; Tarumi T; Takano H; Fukada Y; Nishio M; Katagiri E; Yasukouchi T; Sato N; Sekiguchi S; Koike T
    Exp Hematol; 1998 Nov; 26(12):1140-7. PubMed ID: 9808053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of cytokines on CD34+ Rh-123high and low progenitor cells from human umbilical cord blood.
    Cicuttini FM; Welch KL; Boyd AW
    Exp Hematol; 1994 Dec; 22(13):1244-51. PubMed ID: 7525327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.